The United States National Institutes of Health (NIH) is committed to setting research priorities that advance progress toward viral hepatitis elimination. In addition to basic research to understand the molecular processes of viral hepatitis infection, NIH focuses on development of new vaccines, diagnostics, treatments and other interventions to prevent acute and chronic hepatitis infection and related disease.
In 2021, NIH and the Coalition for Global Hepatitis Elimination launched a new webinar series, Moving from Hepatitis Discovery to Elimination: NIH Research Advancing Hepatitis Elimination. The objectives of the series are to highlight ongoing research that can benefit elimination efforts, support translation of research into implementation, and identify additional research needs.
Six webinars were held during the period March-September 2021. Webinar recording and slide presentations are available online for each webinar and can be accessed here:
- Kick-Off: The road to elimination and the role of NIH research (first webinar, 4 March 2021)
- Collaborative research on hepatitis C identification and treatment among persons who inject drugs (second webinar, 8 April 2021)
- Leaving no one behind: Research to uncover and address health disparities in hepatitis burden of disease and cure (third webinar, 13 May 2021)
- Improving early detection of HCC: The Quest for New Biomarkers (fourth webinar, 8 July 2021)
- Hepatitis D Virus Virtual Symposium: Virology, Epidemiology, Clinical Features, Diagnosis, Management, Therapy (fifth webinar, 9 September 2021)
- Elimination of Perinatal HBV and HCV Transmission: New opportunities to improve screening, prevention and care (sixth webinar, 14 October 2021)